Health
Despite COVID-19 setbacks, WHO aims to eliminate lymphatic filariasis by 2030 – News-Medical.Net
In 2019, 538.1 million people were treated for lymphatic filariasis (LF) in 38 countries that implemented mass drug administration (MDA) of populations at risk…
Reviewed by Emily Henderson, B.Sc.Nov 2 2020
In 2019, 538.1 million people were treated for lymphatic filariasis (LF) in 38 countries that implemented mass drug administration (MDA) of populations at risk of the disease, as recommended by the World Health Organization (WHO).
Seventeen countries achieved the criteria for elimination of LF as a public health problem; Kiribati, Malawi and Yemen were the latest to be acknowledged by WHO.
The Global Programme to Eliminate Lymphatic Filariasis (GPELF)…
-
Noosa News16 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News23 hours agoAbout 90,000 households remain without power after severe storms with giant hail lash south-east Queensland
-
General19 hours agoSister Kate’s site to become home to Perth’s first Aboriginal aged care facility
-
General17 hours agoLabor to squeeze public service, sparking warnings of job losses